Eversheds Sutherland advises on the financing round of Methinks AI

Eversheds Sutherland España has advised EIC Fund in a financing round in Methinks AI, a digital health company specializing in early detection and management of acute stroke patients using artificial intelligence (AI).

Methinks AI

Barcelona-based company with a vision to provide universal and timely healthcare to enable life-saving treatments worldwide. Its primary focus is on stroke, a leading cause of disability and the second leading cause of death worldwide.

Methinks Stroke Suite, has recently received CE marking. This innovative solution accelerates treatment time in any hospital by analyzing basic medical images, such as non-contrast CT scans. In stroke cases, “time is brain,” where every minute counts and influences the risk of disability or even death.

This advice is in line with the long-term collaboration agreement between Eversheds Sutherland and the European Innovation Council Fund (EIC Fund), in which the European Investment Bank (EIB) acts as investment advisor to the fund and Eversheds acts as advisor in assisting the EIC Fund.

Leading the Eversheds-Sutherland team in Spain were Sixto de la Calle Peral, head of private equity, María Ramalle Quiñones, legal director and Mercedes Olmedo González, associate in the M&A practice.